VACCINES LICENSED IN THE UNITED STATES AND THEIR ROUTES OF ADMINISTRATION
|
VACCINE
*
|
TYPE
|
ROUTE
|
|
Adenovirus‡ |
Live Virus | Oral |
|
Anthrax§
|
Inactivated Virus | Subcutaneous |
|
BCG
|
Live Bacteria | Subcutaneous, Intramuscular, & Intradermal |
|
Cholera
|
Inactivated Virus | Intradermal (preferred), or Subcutaneous |
|
Ditptheria-tetanus
(dT, DT)
|
Toxoids | Intramuscular |
|
DTP
|
Toxoids and inactivated bacteria | Intramuscular |
|
DTaP
|
Toxoids and inactivated bacterial components | Intramuscular |
|
Hepatitis
A
|
Inactivated
viral antigen
|
Intramuscular |
|
Hepatitis B |
Inactivated viral antigen | Intramuscular |
|
Hib
Conjugates¶
|
Polysaccharide-protien conjugate | Intramuscular |
|
Hib
Conjugates - DTP (HbOC¶
- DTP and PRP-T¶ reconstituted
with DTP)
|
Polysaccharide-protien conjugate with toxoids and inactivated bacteria | IIntramuscular |
|
Hib
Conjugates - DTaP (PRP-T¶ reconstituted
with DTaP)
|
Polysaccharide-protien conjugate with toxoids and inactivated bacterial components | Intramuscular |
|
Hib
Conjugate (PRP-OMP¶)
- hepatitis B
|
Polysaccharide-protien
conjugate with inactivated bacteria
|
Intramuscular |
|
Influenza
|
Inactivated Virus (whole virus), viral components | Intramuscular |
|
Japanese
encephalitis
|
Inactivated Virus | Subcutaneous |
|
Lyme
Disease
|
Inactivated Protein | Intramuscular |
|
Measels
|
Live Virus | Subcutaneous |
|
Meningococcal
|
Polysaccharide | Subcutaneous |
|
MMR
|
Live Viruses | Subcutaneous |
|
Measels-rubella
|
Live Viruses | Subcutaneous |
|
Mumps
|
Live Virus | Subcutaneous |
|
Pertussis§
|
Inactivated Bacteria | Intramuscular |
|
Plague
|
Inactivated Bacteria | Intramuscular |
|
Pneumococcal
|
Polysaccharide | Intramuscular or Subcutaneous |
|
Poliovirus
IPV OPV |
Inactivated Virus Live Virus |
Subcutaneous Oral |
|
Rabies
|
Inactivated Virus | Intramuscular or Intradermal± |
|
Rubella
|
Live Virus | Subcutaneous |
|
Tetanus
|
Toxoid | Intradermal |
|
Typhoid
Parenteral Parenteral Oral |
Inactivated Bacteria Capsular Polysaccharide Live Bacteria |
Subcutaneous Subcutaneous (boosters may be Intradermal) Oral |
|
Varicella
|
Live Virus | Subcutaneous |
|
Yellow
Fever
|
Live Virus | Subcutaneous |
* BCG indicates bacillus Calmette-Guerin; DTP, diptheria and tetanus toxoids and pertussis, absorbed; DTaP, diptheria and tetanus toxoids and acellular pertussis, absorbed; Hib, Haemophilus influenzae type b; MMR, live measels-mumps-rubella viruses; OPV, oral poliovirus; IPV, inactivated poliovirus; dT,diptheria and tetanus toxoids (for children 7 years of age or older and adults0; DT, diptheria and tetanus toxoids (for children younger than 7 years of age).
‡ Available only to US Armed Forces. No longer being manufactured; existing supplies continue to be used.
§ Disrtibuted by Bio Port Corporation, Lansing MI.
¶ HbOC (diptheria CRM197 protein conjugate), PRP-OMP,(polyribosylribotol phosphate-outer membrane protein), and PRP-T are recommended for infants beginning at approxiamtely 2 months of age.
± Human diploid cell rabies vaccinefor intradeermal use is different in constituion and potency from the intramuscular vaccine; it should be used for preexposure immunization only. Rabies vaccine absorbed and RabAvert should not be given intradermally.